Impact of HIV infection on non-AIDS mortality among Italian injecting drug users

Mauro Zaccarelli, Pietro Gattari, Giovanni Rezza, Susanna Conti, Laura Spizzichino, David Vlahov, Giuseppe Ippolito, Vittorio Lelli, Carlo Valenzi

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Objectives: To estimate the excess mortality of injecting drug users (IDU) stratified by HIV serostatus compared with the general population in Italy. To compare total and cause-specific mortality in HIV-positive versus HIV-negative IDU, in order to identify possible HIV-related non-AIDS causes of death in this population. Methods: All IDU attending two drug-treatment centres in Rome who underwent HIV testing between 1985 and 1991 were enrolled into a prospective study. The end-point of the study was death from any cause by 31 December 1991. Mortality rates were compared using age-adjusted standardized mortality ratios and person-time techniques. Results: Of the 2431 IDU, 1661 (68.3%) were HIV-seronegative and 82 seroconverted. Of 181 deaths, comprising 89 from AIDS and 92 from other causes, the mortality rate was 4.5 and 0.8 per 100 person-years in HIV-seropositives and HIV-seronegatives, respectively. For non-AIDS mortality in HIV-seropositives, the overall rate was 1.7 per 100 person-years. Deaths from overdose and endocarditis/embolus tended to be higher in HIV-seropositive than HIV-seronegative IDU, although there was no difference in the rate of deaths due to pneumonia by HIV serostatus. Conclusions: These data are consistent with other studies demonstrating a higher frequency of mortality among HIV-seropositive IDU. The excess in overdose mortality among HIV-seropositives is disturbing and merits further investigation.

Original languageEnglish
Pages (from-to)345-350
Number of pages6
JournalAIDS (London, England)
Volume8
Issue number3
Publication statusPublished - Mar 1994

Fingerprint

Drug Users
HIV Infections
HIV
Mortality
Cause of Death
Substance Abuse Treatment Centers
Endocarditis
Embolism
Italy
Population
Pneumonia
Acquired Immunodeficiency Syndrome

Keywords

  • HIV infection
  • Injecting drug users
  • Mortality studies
  • Natural history

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Zaccarelli, M., Gattari, P., Rezza, G., Conti, S., Spizzichino, L., Vlahov, D., ... Valenzi, C. (1994). Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS (London, England), 8(3), 345-350.

Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. / Zaccarelli, Mauro; Gattari, Pietro; Rezza, Giovanni; Conti, Susanna; Spizzichino, Laura; Vlahov, David; Ippolito, Giuseppe; Lelli, Vittorio; Valenzi, Carlo.

In: AIDS (London, England), Vol. 8, No. 3, 03.1994, p. 345-350.

Research output: Contribution to journalArticle

Zaccarelli, M, Gattari, P, Rezza, G, Conti, S, Spizzichino, L, Vlahov, D, Ippolito, G, Lelli, V & Valenzi, C 1994, 'Impact of HIV infection on non-AIDS mortality among Italian injecting drug users', AIDS (London, England), vol. 8, no. 3, pp. 345-350.
Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D et al. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS (London, England). 1994 Mar;8(3):345-350.
Zaccarelli, Mauro ; Gattari, Pietro ; Rezza, Giovanni ; Conti, Susanna ; Spizzichino, Laura ; Vlahov, David ; Ippolito, Giuseppe ; Lelli, Vittorio ; Valenzi, Carlo. / Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. In: AIDS (London, England). 1994 ; Vol. 8, No. 3. pp. 345-350.
@article{d6c6f32e722d40279951098434b7cd0e,
title = "Impact of HIV infection on non-AIDS mortality among Italian injecting drug users",
abstract = "Objectives: To estimate the excess mortality of injecting drug users (IDU) stratified by HIV serostatus compared with the general population in Italy. To compare total and cause-specific mortality in HIV-positive versus HIV-negative IDU, in order to identify possible HIV-related non-AIDS causes of death in this population. Methods: All IDU attending two drug-treatment centres in Rome who underwent HIV testing between 1985 and 1991 were enrolled into a prospective study. The end-point of the study was death from any cause by 31 December 1991. Mortality rates were compared using age-adjusted standardized mortality ratios and person-time techniques. Results: Of the 2431 IDU, 1661 (68.3{\%}) were HIV-seronegative and 82 seroconverted. Of 181 deaths, comprising 89 from AIDS and 92 from other causes, the mortality rate was 4.5 and 0.8 per 100 person-years in HIV-seropositives and HIV-seronegatives, respectively. For non-AIDS mortality in HIV-seropositives, the overall rate was 1.7 per 100 person-years. Deaths from overdose and endocarditis/embolus tended to be higher in HIV-seropositive than HIV-seronegative IDU, although there was no difference in the rate of deaths due to pneumonia by HIV serostatus. Conclusions: These data are consistent with other studies demonstrating a higher frequency of mortality among HIV-seropositive IDU. The excess in overdose mortality among HIV-seropositives is disturbing and merits further investigation.",
keywords = "HIV infection, Injecting drug users, Mortality studies, Natural history",
author = "Mauro Zaccarelli and Pietro Gattari and Giovanni Rezza and Susanna Conti and Laura Spizzichino and David Vlahov and Giuseppe Ippolito and Vittorio Lelli and Carlo Valenzi",
year = "1994",
month = "3",
language = "English",
volume = "8",
pages = "345--350",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - Impact of HIV infection on non-AIDS mortality among Italian injecting drug users

AU - Zaccarelli, Mauro

AU - Gattari, Pietro

AU - Rezza, Giovanni

AU - Conti, Susanna

AU - Spizzichino, Laura

AU - Vlahov, David

AU - Ippolito, Giuseppe

AU - Lelli, Vittorio

AU - Valenzi, Carlo

PY - 1994/3

Y1 - 1994/3

N2 - Objectives: To estimate the excess mortality of injecting drug users (IDU) stratified by HIV serostatus compared with the general population in Italy. To compare total and cause-specific mortality in HIV-positive versus HIV-negative IDU, in order to identify possible HIV-related non-AIDS causes of death in this population. Methods: All IDU attending two drug-treatment centres in Rome who underwent HIV testing between 1985 and 1991 were enrolled into a prospective study. The end-point of the study was death from any cause by 31 December 1991. Mortality rates were compared using age-adjusted standardized mortality ratios and person-time techniques. Results: Of the 2431 IDU, 1661 (68.3%) were HIV-seronegative and 82 seroconverted. Of 181 deaths, comprising 89 from AIDS and 92 from other causes, the mortality rate was 4.5 and 0.8 per 100 person-years in HIV-seropositives and HIV-seronegatives, respectively. For non-AIDS mortality in HIV-seropositives, the overall rate was 1.7 per 100 person-years. Deaths from overdose and endocarditis/embolus tended to be higher in HIV-seropositive than HIV-seronegative IDU, although there was no difference in the rate of deaths due to pneumonia by HIV serostatus. Conclusions: These data are consistent with other studies demonstrating a higher frequency of mortality among HIV-seropositive IDU. The excess in overdose mortality among HIV-seropositives is disturbing and merits further investigation.

AB - Objectives: To estimate the excess mortality of injecting drug users (IDU) stratified by HIV serostatus compared with the general population in Italy. To compare total and cause-specific mortality in HIV-positive versus HIV-negative IDU, in order to identify possible HIV-related non-AIDS causes of death in this population. Methods: All IDU attending two drug-treatment centres in Rome who underwent HIV testing between 1985 and 1991 were enrolled into a prospective study. The end-point of the study was death from any cause by 31 December 1991. Mortality rates were compared using age-adjusted standardized mortality ratios and person-time techniques. Results: Of the 2431 IDU, 1661 (68.3%) were HIV-seronegative and 82 seroconverted. Of 181 deaths, comprising 89 from AIDS and 92 from other causes, the mortality rate was 4.5 and 0.8 per 100 person-years in HIV-seropositives and HIV-seronegatives, respectively. For non-AIDS mortality in HIV-seropositives, the overall rate was 1.7 per 100 person-years. Deaths from overdose and endocarditis/embolus tended to be higher in HIV-seropositive than HIV-seronegative IDU, although there was no difference in the rate of deaths due to pneumonia by HIV serostatus. Conclusions: These data are consistent with other studies demonstrating a higher frequency of mortality among HIV-seropositive IDU. The excess in overdose mortality among HIV-seropositives is disturbing and merits further investigation.

KW - HIV infection

KW - Injecting drug users

KW - Mortality studies

KW - Natural history

UR - http://www.scopus.com/inward/record.url?scp=0028265755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028265755&partnerID=8YFLogxK

M3 - Article

C2 - 8031512

AN - SCOPUS:0028265755

VL - 8

SP - 345

EP - 350

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 3

ER -